New Zealand markets closed

GSK plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
45.15-0.63 (-1.38%)
At close: 04:00PM EDT
45.21 +0.06 (+0.13%)
Pre-market: 04:01AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 92.23B
Enterprise value 109.62B
Trailing P/E 16.32
Forward P/E 11.29
PEG ratio (5-yr expected) 1.19
Price/sales (ttm)2.38
Price/book (mrq)5.23
Enterprise value/revenue 2.80
Enterprise value/EBITDA 10.26

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 331.86%
S&P500 52-week change 325.26%
52-week high 345.93
52-week low 333.33
50-day moving average 342.47
200-day moving average 338.81

Share statistics

Avg vol (3-month) 33.21M
Avg vol (10-day) 34.13M
Shares outstanding 52.04B
Implied shares outstanding 62.11B
Float 83.94B
% held by insiders 10.06%
% held by institutions 115.34%
Shares short (30 Apr 2024) 48.99M
Short ratio (30 Apr 2024) 42.88
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.44%
Shares short (prior month 28 Mar 2024) 44.83M

Dividends & splits

Forward annual dividend rate 41.5
Forward annual dividend yield 43.33%
Trailing annual dividend rate 30.59
Trailing annual dividend yield 31.29%
5-year average dividend yield 44.94
Payout ratio 453.43%
Dividend date 311 Jul 2024
Ex-dividend date 416 May 2024
Last split factor 21226:1000
Last split date 322 Jul 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 14.59%
Operating margin (ttm)30.52%

Management effectiveness

Return on assets (ttm)9.31%
Return on equity (ttm)38.78%

Income statement

Revenue (ttm)30.74B
Revenue per share (ttm)15.15
Quarterly revenue growth (yoy)5.90%
Gross profit (ttm)N/A
Net income avi to common (ttm)4.48B
Diluted EPS (ttm)2.77
Quarterly earnings growth (yoy)-29.80%

Balance sheet

Total cash (mrq)4.1B
Total cash per share (mrq)1
Total debt (mrq)17.77B
Total debt/equity (mrq)134.34%
Current ratio (mrq)0.87
Book value per share (mrq)3.39

Cash flow statement

Operating cash flow (ttm)7.67B
Levered free cash flow (ttm)5.63B